In 2019, Tapinarof (1% benvitimod cream), a natural AHR agonist, was officially approved by the Chinese government for the treatment of psoriasis following successful clinical trials in China (Furue, Hashimoto-Hachiya & Tsuji, 2019). Here, AHR is linked to psoriasis.